Related references
Note: Only part of the references are listed.The reproducibility of serum anti-Mullerian hormone in subfertile women: within and between patient variability
Oybek Rustamov et al.
FERTILITY AND STERILITY (2011)
AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis
S. L. Broer et al.
HUMAN REPRODUCTION UPDATE (2011)
Anti-Mullerian hormone testing is useful for individualization of stimulation protocols in oocyte donors
Gary S. Nakhuda et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2011)
The role of anti-Mullerian hormone assessment in assisted reproductive technology outcome
Simone L. Broer et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2010)
The use of anti-Mullerian hormone and antral follicle count to predict the potential of oocytes and embryos
Kingshuk Majumder et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2010)
The likelihood of live birth and multiple birth after single versus double embryo transfer at the cleavage stage: a systematic review and meta-analysis
Tarek A. Gelbaya et al.
FERTILITY AND STERILITY (2010)
Female obesity impairs in vitro fertilization outcome without affecting embryo quality
Jose Bellver et al.
FERTILITY AND STERILITY (2010)
Recent cigarette smoking and assisted reproductive technologies outcome
Ariel Fuentes et al.
FERTILITY AND STERILITY (2010)
Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts
J. van Disseldorp et al.
HUMAN REPRODUCTION (2010)
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
A. La Marca et al.
HUMAN REPRODUCTION UPDATE (2010)
Discordances between follicle stimulating hormone (FSH) and anti-Mullerian hormone (AMH) in female infertility
Norbert Gleicher et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2010)
The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count
Simtone L. Broer et al.
FERTILITY AND STERILITY (2009)
Circulating basal anti-Mullerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization
Luciano G. Nardo et al.
FERTILITY AND STERILITY (2009)
Comparing anti-Mullerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function
David H. Barad et al.
FERTILITY AND STERILITY (2009)
Highly purified hMG achieves better pregnancy rates in IVF cycles but not ICSI cycles compared with recombinant FSH: a meta-analysis
Hesham G. Al-Inany et al.
GYNECOLOGICAL ENDOCRINOLOGY (2009)
The direct health services costs of providing assisted reproduction services in overweight or obese women: a retrospective cross-sectional analysis
Abha Maheshwari et al.
HUMAN REPRODUCTION (2009)
Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception
Scott M. Nelson et al.
HUMAN REPRODUCTION (2009)
Effects of cigarette smoking upon clinical outcomes of assisted reproduction: a meta-analysis
A. L. Waylen et al.
HUMAN REPRODUCTION UPDATE (2009)
Advances and Controversies in Assisted Reproductive Technology
Gerardo Vela et al.
MOUNT SINAI JOURNAL OF MEDICINE (2009)
Single-embryo transfer reduces clinical pregnancy rates and live births in fresh IVF and Intracytoplasmic Sperm Injection (ICSI) cycles: a meta-analysis
Ricardo L. R. Baruffi et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2009)
Biological versus chronological ovarian age: implications for assisted reproductive technology
Carlo Alviggi et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2009)
Impact of female age and male infertility on ovarian reserve markers to predict outcome of assisted reproduction technology cycles
Tsung-Hsien Lee et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2009)
Infertility treatment outcome in sub groups of obese population
Khalid A. Awartani et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2009)
A modern classification of OHSS
Abraham Golan et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2009)
Anti-Mullerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients
Eman A. Elgindy et al.
FERTILITY AND STERILITY (2008)
Statistically significant changes of antimuillerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women
Dorothea M. Wunder et al.
FERTILITY AND STERILITY (2008)
Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients
Peter G. A. Hompes et al.
FERTILITY AND STERILITY (2008)
Relevance of anti-Mullerian hormone measurement in a routine IVF program
C. Gnoth et al.
HUMAN REPRODUCTION (2008)
Flexible GnRH antagonist versus flare-up GnRH agonist protocol in poor responders treated by IVF: a randomized controlled trial
Trifon G. Lainas et al.
HUMAN REPRODUCTION (2008)
Active smoking compromises IVF outcome and affects ovarian reserve
Thomas Freour et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2008)
Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis
Arri Coomarasamy et al.
HUMAN REPRODUCTION (2008)
Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF
Soren Ziebe et al.
HUMAN REPRODUCTION (2007)
Anti-Mullerian hormone levels and antral follicle count in women enrolled in in vitro fertilization cycles: Relationship to lifestyle factors, chronological age and reproductive history
Luciano G. Nardo et al.
GYNECOLOGICAL ENDOCRINOLOGY (2007)
Stable serum levels of anti-Mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women
S. Tsepelidis et al.
HUMAN REPRODUCTION (2007)
Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology
A. La Marca et al.
HUMAN REPRODUCTION (2007)
Measurement of serum Anti-Mullerian hormone by Beckman Coulter ELISA and DSL ELISA: Comparison and relevance in Assisted Reproduction Technology (ART)
Thomas Freour et al.
CLINICA CHIMICA ACTA (2007)
Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles - implications for individualization of therapy
Scott M. Nelson et al.
HUMAN REPRODUCTION (2007)
Serum anti-Mullerian hormone throughout the human menstrual cycle
A. La Marca et al.
HUMAN REPRODUCTION (2006)
A systematic review of tests predicting ovarian reserve and IVF outcome
F. J. Broekmans et al.
HUMAN REPRODUCTION UPDATE (2006)
Number of embryos for transfer after IVF and ICSI: a Cochrane review
Z Pandian et al.
HUMAN REPRODUCTION (2005)
Fertility and ageing
DT Baird et al.
HUMAN REPRODUCTION UPDATE (2005)
ABC of subfertility assisted conception. I - General principles
P Rowell et al.
BRITISH MEDICAL JOURNAL (2003)
Comparison of controlled ovarian stimulation with human menopausal gonadotropin or recombinant follicle-stimulating hormone
M Filicori et al.
FERTILITY AND STERILITY (2003)
Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis
M van Wely et al.
FERTILITY AND STERILITY (2003)
The variability of female reproductive ageing
ERT Velde et al.
HUMAN REPRODUCTION UPDATE (2002)
One versus two embryo transfer after IVF and ICSI:: a randomized study
H Martikainen et al.
HUMAN REPRODUCTION (2001)
Conventional in-vitro fertilisation versus intracytoplasmic sperm injection for the treatment of non-male-factor infertility: a randomised controlled trial
S Bhattacharya et al.
LANCET (2001)
Investigation of the infertile couple - Investigation of the infertile couple in the era of assisted reproductive technology: a time for reappraisal
J Balasch
HUMAN REPRODUCTION (2000)
Share Paper
